![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Myo1g | Rat | (-)-cotinine | affects methylation | ISO | RGD:1314390 | 6480464 | Cotinine affects the methylation of MYO1G gene | CTD | PMID:22851337 | Myo1g | Rat | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1314391 | 6480464 | 1,2-Dimethylhydrazine results in increased expression of MYO1G mRNA | CTD | PMID:22206623 | Myo1g | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1314391 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MYO1G mRNA | CTD | PMID:26377647 | Myo1g | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MYO1G mRNA | CTD | PMID:34747641 | Myo1g | Rat | 2-butoxyethanol | decreases expression | ISO | RGD:1314391 | 6480464 | n-butoxyethanol results in decreased expression of MYO1G mRNA | CTD | PMID:19812364 | Myo1g | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1314391 | 6480464 | Fenretinide results in decreased expression of MYO1G mRNA | CTD | PMID:28973697 | Myo1g | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of MYO1G mRNA | CTD | PMID:31881176 | Myo1g | Rat | aflatoxin B1 | increases methylation | ISO | RGD:1314390 | 6480464 | Aflatoxin B1 results in increased methylation of MYO1G exon; Aflatoxin B1 results in increased methylation more ... | CTD | PMID:28458013|PMID:30157460 | Myo1g | Rat | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1314390 | 6480464 | aflatoxin B2 results in increased methylation of MYO1G exon | CTD | PMID:30157460 | Myo1g | Rat | all-trans-retinoic acid | increases expression | ISO | RGD:1314390 | 6480464 | Tretinoin results in increased expression of MYO1G mRNA | CTD | PMID:33167477 | Myo1g | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of MYO1G mRNA | CTD | PMID:35163327 | Myo1g | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of MYO1G mRNA | CTD | PMID:30779732 | Myo1g | Rat | antirheumatic drug | decreases expression | ISO | RGD:1314390 | 6480464 | Antirheumatic Agents results in decreased expression of MYO1G mRNA | CTD | PMID:24449571 | Myo1g | Rat | aristolochic acid A | increases expression | ISO | RGD:1314390 | 6480464 | aristolochic acid I results in increased expression of MYO1G mRNA | CTD | PMID:33212167 | Myo1g | Rat | benzo[a]pyrene | increases expression | ISO | RGD:1314390 | 6480464 | Benzo(a)pyrene results in increased expression of MYO1G mRNA | CTD | PMID:20064835|PMID:30453624 | Myo1g | Rat | benzo[a]pyrene | affects methylation | ISO | RGD:1314390 | 6480464 | Benzo(a)pyrene affects the methylation of MYO1G exon; Benzo(a)pyrene affects the methylation of MYO1G promoter | CTD | PMID:27901495|PMID:30157460 | Myo1g | Rat | benzo[a]pyrene | decreases methylation | ISO | RGD:1314390 | 6480464 | Benzo(a)pyrene results in decreased methylation of MYO1G 3' UTR | CTD | PMID:27901495 | Myo1g | Rat | benzo[a]pyrene | multiple interactions | ISO | RGD:1314391 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Myo1g | Rat | benzo[a]pyrene | increases expression | ISO | RGD:1314391 | 6480464 | Benzo(a)pyrene results in increased expression of MYO1G mRNA | CTD | PMID:22228805 | Myo1g | Rat | benzo[a]pyrene | decreases expression | ISO | RGD:1314391 | 6480464 | Benzo(a)pyrene results in decreased expression of MYO1G mRNA | CTD | PMID:21569818 | Myo1g | Rat | benzo[b]fluoranthene | increases expression | ISO | RGD:1314391 | 6480464 | benzo(b)fluoranthene results in increased expression of MYO1G mRNA | CTD | PMID:26377693 | Myo1g | Rat | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1314391 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Myo1g | Rat | benzo[e]pyrene | increases methylation | ISO | RGD:1314390 | 6480464 | benzo(e)pyrene results in increased methylation of MYO1G exon | CTD | PMID:30157460 | Myo1g | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MYO1G mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | Myo1g | Rat | bisphenol A | increases expression | ISO | RGD:1314391 | 6480464 | bisphenol A results in increased expression of MYO1G mRNA | CTD | PMID:32156529|PMID:38701888 | Myo1g | Rat | bisphenol A | decreases expression | ISO | RGD:1314390 | 6480464 | bisphenol A results in decreased expression of MYO1G protein | CTD | PMID:33376534 | Myo1g | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MYO1G gene | CTD | PMID:28505145 | Myo1g | Rat | buta-1,3-diene | decreases expression | ISO | RGD:1314391 | 6480464 | 1,3-butadiene results in decreased expression of MYO1G mRNA | CTD | PMID:29038090 | Myo1g | Rat | cadmium atom | decreases expression | ISO | RGD:1314391 | 6480464 | Cadmium results in decreased expression of MYO1G mRNA | CTD | PMID:23358151 | Myo1g | Rat | cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of MYO1G mRNA | CTD | PMID:22110744 | Myo1g | Rat | carbon nanotube | affects expression | ISO | RGD:1314391 | 6480464 | Nanotubes, Carbon analog affects the expression of MYO1G mRNA | CTD | PMID:25554681 | Myo1g | Rat | carbon nanotube | increases expression | ISO | RGD:1314391 | 6480464 | Nanotubes, Carbon results in increased expression of MYO1G mRNA | CTD | PMID:25554681 | Myo1g | Rat | chloroprene | decreases expression | ISO | RGD:1314391 | 6480464 | Chloroprene results in decreased expression of MYO1G mRNA | CTD | PMID:23125180 | Myo1g | Rat | chrysene | multiple interactions | ISO | RGD:1314391 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Myo1g | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of MYO1G mRNA | CTD | PMID:27523638 | Myo1g | Rat | Dibutyl phosphate | affects expression | ISO | RGD:1314390 | 6480464 | di-n-butylphosphoric acid affects the expression of MYO1G mRNA | CTD | PMID:37042841 | Myo1g | Rat | dimethyl sulfoxide | increases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in increased expression of MYO1G mRNA | CTD | PMID:22193206 | Myo1g | Rat | dimethylarsinic acid | multiple interactions | ISO | RGD:1314391 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Myo1g | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression more ... | CTD | PMID:33729688 | Myo1g | Rat | diquat | decreases expression | ISO | RGD:1314391 | 6480464 | Diquat results in decreased expression of MYO1G mRNA | CTD | PMID:36851058 | Myo1g | Rat | diuron | decreases expression | ISO | RGD:1314390 | 6480464 | Diuron results in decreased expression of MYO1G mRNA | CTD | PMID:35967413 | Myo1g | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MYO1G mRNA | CTD | PMID:24136188 | Myo1g | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MYO1G mRNA | CTD | PMID:22061828 | Myo1g | Rat | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of MYO1G mRNA | CTD | PMID:24136188 | Myo1g | Rat | GSK-J4 | decreases expression | ISO | RGD:1314390 | 6480464 | GSK-J4 results in decreased expression of MYO1G mRNA | CTD | PMID:29301935 | Myo1g | Rat | methapyrilene | increases methylation | ISO | RGD:1314390 | 6480464 | Methapyrilene results in increased methylation of MYO1G exon | CTD | PMID:30157460 | Myo1g | Rat | methylarsonic acid | multiple interactions | ISO | RGD:1314391 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Myo1g | Rat | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of MYO1G mRNA | CTD | PMID:31378766 | Myo1g | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of MYO1G mRNA | CTD | PMID:24136188 | Myo1g | Rat | nickel atom | increases expression | ISO | RGD:1314390 | 6480464 | Nickel results in increased expression of MYO1G mRNA | CTD | PMID:25583101 | Myo1g | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of MYO1G mRNA | CTD | PMID:24136188 | Myo1g | Rat | okadaic acid | increases expression | ISO | RGD:1314390 | 6480464 | Okadaic Acid results in increased expression of MYO1G mRNA | CTD | PMID:38832940 | Myo1g | Rat | paracetamol | affects expression | ISO | RGD:1314391 | 6480464 | Acetaminophen affects the expression of MYO1G mRNA | CTD | PMID:17562736 | Myo1g | Rat | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of MYO1G mRNA | CTD | PMID:19162173 | Myo1g | Rat | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MYO1G mRNA | CTD | PMID:19162173 | Myo1g | Rat | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of MYO1G mRNA | CTD | PMID:19162173 | Myo1g | Rat | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of MYO1G mRNA | CTD | PMID:19162173 | Myo1g | Rat | silicon dioxide | increases expression | ISO | RGD:1314391 | 6480464 | Silicon Dioxide results in increased expression of MYO1G mRNA | CTD | PMID:29341224 | Myo1g | Rat | sodium arsenate | multiple interactions | ISO | RGD:1314391 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Myo1g | Rat | sodium arsenite | multiple interactions | ISO | RGD:1314391 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Myo1g | Rat | sodium arsenite | increases expression | ISO | RGD:1314391 | 6480464 | sodium arsenite results in increased expression of MYO1G mRNA | CTD | PMID:36209798 | Myo1g | Rat | sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of MYO1G mRNA | CTD | PMID:22110744 | Myo1g | Rat | sulforaphane | decreases expression | ISO | RGD:1314390 | 6480464 | sulforaphane results in decreased expression of MYO1G mRNA | CTD | PMID:31838189 | Myo1g | Rat | tetraphene | increases expression | ISO | RGD:1314391 | 6480464 | benz(a)anthracene results in increased expression of MYO1G mRNA | CTD | PMID:26377693 | Myo1g | Rat | tetraphene | multiple interactions | ISO | RGD:1314391 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Myo1g | Rat | titanium dioxide | increases expression | ISO | RGD:1314391 | 6480464 | titanium dioxide results in increased expression of MYO1G mRNA | CTD | PMID:23557971 | Myo1g | Rat | titanium dioxide | decreases methylation | ISO | RGD:1314391 | 6480464 | titanium dioxide results in decreased methylation of MYO1G promoter | CTD | PMID:35295148 | Myo1g | Rat | titanium dioxide | decreases expression | ISO | RGD:1314391 | 6480464 | titanium dioxide results in decreased expression of MYO1G mRNA | CTD | PMID:27760801|PMID:29264374 | Myo1g | Rat | triptonide | increases expression | ISO | RGD:1314391 | 6480464 | triptonide results in increased expression of MYO1G mRNA | CTD | PMID:33045310 | Myo1g | Rat | urethane | decreases expression | ISO | RGD:1314390 | 6480464 | Urethane results in decreased expression of MYO1G mRNA | CTD | PMID:28818685 | Myo1g | Rat | valproic acid | decreases methylation | ISO | RGD:1314390 | 6480464 | Valproic Acid results in decreased methylation of MYO1G gene | CTD | PMID:29154799 | |